Lallemand inaugurates its newest division - Lallemand Health Solutions
Montreal, Canada... Lallemand Inc is pleased to announce the birth of its new division Lallemand Health Solutions.
Montreal, Canada... Lallemand Inc is pleased to announce the birth of its new division ‘’Lallemand Health Solutions’’. This new entity consolidates the internationally recognized probiotic manufacturers Institut Rosell and Harmonium International. Collectively they possess close to a century of probiotic expertise in the selection, development, production and marketing of probiotic strains, and formulations that support human health and well-being.
Lallemand Health Solutions will be dedicated in bringing to its customers, which span from the food supplement to the pharmaceutical industries, the highest quality probiotic solutions produced within current GMP and ISO 9001 environments. Thanks to its fully integrated offer ‘’Lallemand Health Solutions’’ is a unique probiotic player in the global arena that can provide its customers and partners solutions from fermentation and lyophilization all the way to finished product capabilities; a true one stop shop probiotic solutions provider.
The new division, headquartered in Montreal, Canada, is managed by Mrs. Francine Mondou, former co-founder and president of Harmonium International and is covering more than 30 countries across 5 continents ready to service your probiotic needs.
‘’Lallemand Health Solutions’’ recognized also as ‘’LHS’’, offers a full line of ready-to-market probiotic formula’s such as ; LACIDOFIL®, PROBIO’KID®, PRIOBIO’STICK®, PROTECFLOR® , can also design, develop and produce custom formulations based on the documented ROSELL®, LAFTI® or HARMONIUM® strains. Such formulations can also include premium vitamin and mineral yeasts or β-Glucans, developed and produced by the Lallemand group under the LALMIN® brand. All formulations can be delivered in bulk powder or finished product formats such as: capsules, tablets, sachets, sticks, and bottles.
Available ready-to-market probiotic blends targeting specific health segments:
• Gastrointestinal health: IBS, AAD, travelers diarrhea, …
• Immunity: kids and adults
• Women healthcare: UTI, Candidiasis, …
• Stress and anxiety
From the lab to shelf, ‘’Lallemand Health Solutions’’ controls the overall manufacturing process of its products. Our probiotic strains and formulas are produced in-house in one of our many bacteria and yeast production facilities available at the Lallemand Group to ensure customers are receiving the highest quality standard of probiotic formulations.
Institut Rosell Inc. was founded by microbiologists Dr Rosell and Dr Edouard Brochu in 1934 in Montreal and stands as a pioneer of probiotics development in North America. The Institut was acquired by the Lallemand group in 1998. Since then, with intensive research programs and a solid international partnership network with renowned research institutes, hospitals and universities, the company has always pursued its founder’s mission to document and demonstrate the benefits of probiotics on health and well-being.
Harmonium International Inc. was created in 1998 in Montreal and incorporated into Lallemand in 2011. Harmonium International's mission remains simple to this day; apply our know-how into producing unmatched quality probiotic micro-organisms, add a good portion of great customer service, personally educate and train our business partners on the health benefits of good bacteria, and formulate the best probiotic complexes to meet our clients’ needs. These longstanding ingredients have become the formula for Harmonium’s success, credibility and a reference to high quality probiotics.
Related News
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva. -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
News US FDA does not approve MDMA therapy for PTSD, requests more data
The MDMA-based therapeutic developed by Lykos Therapeutics, a California-based Public Benefit Corporation (PBC), has been reviewed and unapproved by the US FDA. The regulator has requested additional phase III trial data for further safety and efficacy... -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production. -
News Novel oral Type 1 diabetes drug gains US FDA IND designation
A University of Alabama at Birmingham startup has gained FDA clearance for Investigational New Drug clinical trials for an oral Type 1 diabetes drug, a milestone for diabetes treatment. -
News A Day in the Life of a Vice President in R&D & Engineering
In the Day in the Life of Series, we've already had the chance to get to know a range of people in various roles in the pharma industry. In the latest interview we get a glimpse into the R&D side of things from Jennifer Sorrells, Vice Presiden...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance